Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

Background & Aims: Patients affected by hepatocellular carcinoma (HCC) represent a vulnerable population during the COVID-19 pandemic and may suffer from altered allocation of healthcare resources. The aim of this study was to determine the impact of the COVID-19 pandemic on the management o...

Full description

Bibliographic Details
Main Authors: Giuliana Amaddeo, Raffaele Brustia, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, Lorraine Blaise, Nathalie Ganne-Carrié, Olivier Séror, Edouard Larrey, Chetana Lim, Olivier Scatton, Sanaa El Mouhadi, Violaine Ozenne, François Paye, Pierre Balladur, Anthony Dohan, Pierre-Philippe Massault, Stanislas Pol, Marco Dioguardi Burgio, Valérie Vilgrain, Ailton Sepulveda, Francois Cauchy, Alain Luciani, Daniele Sommacale, Vincent Leroy, Francoise Roudot-Thoraval, Mohamed Bouattour, Jean-Charles Nault
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:JHEP Reports
Subjects:
2019-nCoV
COVID-19
Management
Hepatocellular carcinoma
Cirrhosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555920301336

Internet

http://www.sciencedirect.com/science/article/pii/S2589555920301336

Similar Items